Latest Angiogenesis Stories
Significant increases were shown in the protein Kallistatin, a potent vasodilator Purchase, NY (PRWEB) March 31, 2015 Nutrition 21, LLC (“Nutrition
Efficacy and Safety of Long-term, Continuous Anti-VEGF will be Assessed in Phase 2 Study CUMBERLAND, R.I., March 30, 2015 /PRNewswire/ -- Neurotech Pharmaceuticals, Inc.
DALLAS, March 26, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Myocardial Ischemia - Pipeline Review, H1 2015" therapeutic market research report provides an overview
Long Island Joins Atlanta, Chicago and Philadelphia Study Centers for CardioCell's Chronic Heart Failure Clinical Trial Using Ischemia-Tolerant Mesenchymal Stem Cells (itMSCs) STONY
DALLAS, March 2, 2015 /PRNewswire/ -- ReportsnReports.com adds Lonsurf and Avastin (Colorectal Cancer) - Forecast and Market Analysis to 2023 research report focuses on
USPTO awards patent for combination use of modified citrus pectin and honokiol extract, with potential to inhibit growth of numerous types of cancer SANTA ROSA, Calif., Feb.
New Insights, Discoveries and Interim Clinical Data on Generx® Phase 3 Angiogenic Therapy for Patients with Cardiac Microvascular Insufficiency and Coronary Artery Disease SAN DIEGO,
-- DIG-KT is a novel bi-specific mAb targeting VEGFR2 and Tie-2 pathways for treating cancers SHENYANG, China and DAEJEON, South Korea, Jan. 14, 2015 /PRNewswire/ -- 3SBio Inc.
RnRMarketResearch.com adds "Avastin and Cyramza (Colorectal Cancer) - Forecast and Market Analysis to 2023" to its store.
Announces Formation of Angionetics and Activation Therapeutics: New Operating Units to Facilitate the Independent Monetization and Funding of Generx® and Excellagen® SAN DIEGO, Nov.
- A bereavement by loss of parents or children; the state of being orbate; orbation.